ARCT vs AVIR: stock comparison and AI forecast
Arcturus Therapeutics Holdings Inc. (ARCT) and Atea Pharmaceuticals, Inc. (AVIR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ARCT Arcturus Therapeutics Holdings Inc.
- Price
- $12.15 +41.0% · 6M
- Market Cap
- $345M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
AVIR Atea Pharmaceuticals, Inc.
- Price
- $4.17 -25.5% · 6M
- Market Cap
- $334M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ARCT and AVIR have similar market capitalizations ($345M and $334M).
- Over the last six months ARCT returned +41.0% and AVIR -25.5%.
- ARCT carries 0.31 times debt per unit of equity, against 0.14 times for AVIR.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ARCT | AVIR |
|---|---|---|
| Market Cap | $345M | $334M |
| P/B Ratio | 2.01x | 1.64x |
| EPS | $-2.90 | $-1.91 |
| Book Value/Share | $6.04 | $2.55 |
| Revenue/Share | $1.03 | – |
| FCF/Share | $-2.56 | – |
Profitability & Margins
| Metric | ARCT | AVIR |
|---|---|---|
| ROE | -54.3% | -81.0% |
| ROA | -41.6% | -71.2% |
| ROIC | -53.6% | -89.9% |
| Operating Margin | -348.3% | – |
| Net Margin | -317.6% | – |
| EBT Margin | -324.3% | – |
| Tax Rate | 0.0% | 3.8% |
Financial Health
| Metric | ARCT | AVIR |
|---|---|---|
| Current Ratio | 5.88x | 8.13x |
| D/E Ratio | 0.31x | 0.14x |
| Financial Leverage | 1.31x | 1.14x |
| Interest Coverage | 4.4x | – |
| Working Capital | $164M | $201M |
Cash Flow
| Metric | ARCT | AVIR |
|---|---|---|
| Operating Cash Flow | -$73M | -$152M |
| Free Cash Flow | -$73M | – |
| Capital Spending | -$90K | – |
| FCF/Sales | -248.0% | – |
| CapEx/Sales | 0.3% | – |
Operational Efficiency
| Metric | ARCT | AVIR |
|---|---|---|
| Asset Turnover | 0.13x | – |
| Receivables Turnover | 16.2x | – |
| Fixed Assets Turnover | 5.5x | – |
| Days Sales Outstanding | 23 days | – |
Income Statement
| Metric | ARCT | AVIR |
|---|---|---|
| Total Revenue | $29M | – |
| Operating Income | -$102M | -$184M |
| Net Income | -$93M | -$165M |
| R&D Expense | $87M | $155M |
Dividend & Shareholder Information
| Metric | ARCT | AVIR |
|---|---|---|
| Shares Outstanding | 28M | 80M |
ARCT vs AVIR: stock comparison and AI forecast
Which is bigger, ARCT or AVIR?
ARCT and AVIR have similar market capitalizations ($345M and $334M).
Which stock performed better over the last six months, ARCT or AVIR?
Over the last six months ARCT returned +41.0% and AVIR -25.5%.
Which one does Intratio's AI model rank higher, ARCT or AVIR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.